Home » Newsletters » BioWorld Science

BioWorld Science

March 12, 1998

View Archived Issues

Amrad: HY 1997/98 highlights

P&U scientists disclose new MMP inhibitors for connective tissue diseases

Advanced Tissue Sciences: year-end 1997 highlights

Amylin: FY 1997 highlights

Novopharm Biotech: FY 1997 highlights

Cubist's daptomycin shows activity against VISA bacterial strains

AltaRex: Q4 and year-end 1997 highlights

DynaGen allowed U.S. patent for ImmuDyn HIV/AIDS use

U.S. patent awarded for Sertoli cell transplants

Rhone-Poulenc Rorer synthesizes and evaluates new TNF/cAMP PDE inhibitors

New antitumor and immunosuppressive compounds in development at Klinge

Cidofovir demonstrates anti-poxvirus activity in primates

Antithrombotics developed at Warner-Lambert

Novel immunomodulatory agents described by Takeda

Cephalon reports K-252a derivatives for neurology indications

Vasopressin antagonists for treating CHF

Macrolactine M described by Ocean Biotechnology

Novel gastrointestinal agents in early development at Dainippon

Merck investigates antidiabetic/antiobesity agents

SKB azaspiranes exert topical antiinflammatory effects via a novel mechanism of action

FDA approves three-day treatment option for bacterial vaginosis

New testosterone replacement patch launched in U.S.

Isis and Genelabs Technologies announce novel collaborative R&D effort

Chrysalis and Pfizer embark on genomics research collaboration

Sch-40832: a novel thiostrepton antimicrobial agent

Oxandrin approved in Russia

Discovery Laboratories to merge with Acute Therapeutics subsidiary

R.P. Scherer reveals the identity of two more pipeline products

Gemzar approved in Canada

European academics collaborate on R&D of novel NNRTIs

Interim safety data reported for Procysteine

Bristol-Myers Squibb and UT Austin announce cancer collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...